ILLINOIS INSTITUTE OF TECHNOLOGY

Their core work

Illinois Institute of Technology is a private research university in Chicago with strengths spanning engineering, computing, and social sciences. In H2020, they contributed expertise in computational modeling for cardiac medicine (SILICOFCM), fluid-structure interaction dynamics (ConFlex), and social inclusion research (CRISP). As a US-based institution, they serve as a transatlantic bridge, bringing American research capacity into European consortia primarily through Marie Skłodowska-Curie mobility and training networks.

What they specialise in

How they've shifted over time

With only three projects spanning 2016–2018, there is insufficient data to establish a meaningful evolution of focus. Early involvement centered on social sciences and engineering (CRISP in 2016, ConFlex in 2017), while the most recent entry moved into computational health (SILICOFCM in 2018). This may signal a growing interest in simulation-based medicine, but the sample is too small to confirm a trend.

Their most recent and only directly funded project was in computational cardiac simulation, suggesting potential growth in biomedical computing if they continue EU engagement.

How they like to work

IIT has never coordinated an H2020 project, joining exclusively as a partner or third party — consistent with a non-EU institution contributing specialized expertise to European-led consortia. Despite only three projects, they have worked with 48 unique partners across 15 countries, indicating participation in large, broadly distributed consortia. They appear to be a selective transatlantic contributor rather than a frequent EU framework programme participant.

Across just three projects, IIT connected with 48 partners in 15 countries, reflecting participation in large Marie Curie and research networks rather than deep bilateral ties. Their reach is notably broad for such limited direct involvement.

What sets them apart

As a US-based research university, IIT offers something most H2020 participants cannot: a direct link to American research infrastructure, talent, and industry ecosystems. Their involvement through MSCA mobility schemes makes them a natural partner for projects needing transatlantic researcher exchange. For consortium builders, they represent a credible non-EU partner that has already navigated the H2020 participation process.

Highlights from their portfolio

• SILICOFCM
  Their only directly funded H2020 project (EUR 417,750), focused on computational simulation of genetic cardiac disease — a niche intersection of computing and medicine.
• ConFlex
  A 5-year MSCA staff exchange program on fluid-structure interactions, enabling long-term researcher mobility between IIT and European partners.